Case Studies | Cardiology Science | France | Volume 5 Issue 8, August 2016
Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor
TRAN Thanh Huyen MD, PHAM Thanh Dat MD
Introduction Ticagrelor is used for the prevention of thrombotic events in patients with acute coronary syndrome or myocardial infarction with ST elevation. The drug is combined with acetylsalicylic acid (ASA - Aspirin) unless the latter is contraindicated. The FDA indication for ticagrelor is reduction of the rate of cardiovascular death, myocardial infarction (MI), and stroke in people with acute coronary syndrome or history of myocardial infarction. AHA/ACC Guidelines 2014 state It is reasonable to choose ticagrelor over clopidogrel for P2Y12 inhibition treatment in patients with NSTE-ACS treated with early invasive strategy and/or coronary stenting [1]. The most common side effects are shortness of breath (dyspnea, 14 %) and various types of bleeding, such as hematoma, gastrointestinal, subcutaneous, intracranial hemorrhage In addition to this, knowing the contraindications of Ticagrelor to prevent hemorrhagic complications. Case presentation A 60-year-old man was admitted to. He had been receiving loading dose 180mg ticagrelor and 250mg aspirin and Heparin for a recent acute coronary syndrome (ACS) that had been treated with one bare-metal stent and developed a major esophageal bleeding, pericardial effusion. 48 hours later, the patient had a decreased level of consciousness. Computed tomography (CT) revealed an intracranial hemorrhage peri-rolandic. Patient presented a cardiogenic shock (cardiac pump failure related to loss of myocardial contractility) with EF 15 % (under dobutamine) and Hypovolemic shock (due to blood loss) combined. He proceeded to emergency cardiac transplantation operation. Apart from dual antiplatelet therapy (DAPT) with aspirin and ticagrelor, there were no other identified risk factors for increased bleeding. Conclusion In cardiac surgical, patients who are treated with ticagrelor & ASA until and after surgery, ticagrelor therapy is associated with a significantly higher blood loss, a significantly higher use of blood products and coagulation factors and higher incidence of rethoracotomies for bleeding. Consequently, Ticagrelor intake for ACS patients should be avoided or at least discontinued 3 days before cardiac surgery.
Keywords: Cardiac surgery, Ticagrelor, Hemorrhage, Corronary Artery Disease, ACS, Cardiogenic Shock, Hypovolemic shock
Edition: Volume 5 Issue 8, August 2016
Pages: 851 - 853
How to Cite this Article?
TRAN Thanh Huyen MD, PHAM Thanh Dat MD, "Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20161047, Volume 5 Issue 8, August 2016, 851 - 853
40 PDF Views | 39 PDF Downloads
Similar Articles with Keyword 'Cardiac surgery'
Research Paper, Cardiology Science, Bulgaria, Volume 4 Issue 7, July 2015
Pages: 2196 - 2198KIM-1 to Urinary Creatinine Ratio for Early Detection of AKI in Patients Undergoing Cardiopulmonary Bypass
Julieta Hristova, Antoaneta Dimitrova, Georgi Tsaryanski, Kamen Tzatchev, Gencho Nachev
Case Studies, Cardiology Science, India, Volume 5 Issue 5, May 2016
Pages: 1239 - 1241A Case Report: Transcatheter Coil Embolisation for Coronary Artery Fistula from Left Anterior Descending Artery and Drainage to Right Ventricle
Dr. Sainath Hegde, Dr. Prashant Udgire
Research Paper, Cardiology Science, India, Volume 4 Issue 2, February 2015
Pages: 762 - 768A Study to Evaluate the Effect of Music on Pain Intensity and Physiological Parameters among Post - Operative Cardiac Patients in AIIMS, New Delhi
Tarika, Ashia Qureshi, Shashi Mawar, V Devagourou
Research Paper, Cardiology Science, India, Volume 6 Issue 7, July 2017
Pages: 2199 - 2202Procalcitonin and C-Reactive Protein as a Specific Marker of Sepsis in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
Karthick Kavin, Periyasamy T, Shivamuthukumaran, Ramkumar T
Case Studies, Cardiology Science, France, Volume 5 Issue 8, August 2016
Pages: 851 - 853Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor
TRAN Thanh Huyen MD, PHAM Thanh Dat MD
Similar Articles with Keyword 'Hemorrhage'
Informative Article, Cardiology Science, India, Volume 6 Issue 6, June 2017
Pages: 2044 - 2050Study of Clinical Profile and Management of Patients with Pulmonary Embolism using Catheter Directed Thombolysis ? Single Center Study
Sandeep Chaurasia, PP Deshmukh, M Deshpande, S Wasimker, A Tiwari, M Maske, B Patel
Case Studies, Cardiology Science, France, Volume 5 Issue 8, August 2016
Pages: 851 - 853Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor
TRAN Thanh Huyen MD, PHAM Thanh Dat MD
Similar Articles with Keyword 'ACS'
Research Paper, Cardiology Science, Bangladesh, Volume 4 Issue 4, April 2015
Pages: 2081 - 2085AHC/ACC Stenosis Morphology Classification Based Comparison of Coronary Angiographic Lesions in Patients with Acute Coronary Syndrome (ACS) and Chronic Stable Angina (CSA) in a Tertiary Care Centre
Tanjima Parvin, Nafiza Ahmed, Ifat Ara Begum, KMHS Sirajul Haque
Research Paper, Cardiology Science, Egypt, Volume 6 Issue 2, February 2017
Pages: 1292 - 1294The Value of Serum Apelin Measurement in Acute Coronary Syndrome Patients
Ahmed Hamouda Arnaout, Iman Esmat Ibrahim, Lamya Mahmoud Ibrahim
Research Paper, Cardiology Science, India, Volume 8 Issue 6, June 2019
Pages: 945 - 948Necessity of Routine Pre and Post Quantitative Coronary Angiography for all Percutaneous Coronary Interventions with Drug Eluting Stenting
Dr. N. Swaminathan, Dr. G. Panneer Selvam, Dr. S. Venkatesan
Research Paper, Cardiology Science, Albania, Volume 5 Issue 3, March 2016
Pages: 439 - 442The Prevalence of Heart Failure in Hospitalized Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease in Albania
Anida Tulo, Sokol Myftiu, Jonida Klosi, Genc Burazeri
Case Studies, Cardiology Science, France, Volume 5 Issue 8, August 2016
Pages: 851 - 853Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor
TRAN Thanh Huyen MD, PHAM Thanh Dat MD
Similar Articles with Keyword 'Cardiogenic Shock'
Case Studies, Cardiology Science, France, Volume 5 Issue 7, July 2016
Pages: 1631 - 1634Refractory Cardiogenic Shock Induced by Influenza Type B
AZHARI Alaa MD; D'OSTREVY Nicolas; AZARNOUSH Kasra MD PHD; Geoffroy Etienne; MEDARD Anne MD; ULMANN Lucie; CAMILLERI Lionel MD PHD
Case Studies, Cardiology Science, France, Volume 5 Issue 8, August 2016
Pages: 851 - 853Postoperative Bleeding Risk Under Continued the P2Y12 Receptor Antagonists Ticagrelor
TRAN Thanh Huyen MD, PHAM Thanh Dat MD
Research Paper, Cardiology Science, Bulgaria, Volume 7 Issue 11, November 2018
Pages: 26 - 29?arly Versus Lat? Primary Percutan?ous Coronary Angioplasty in Pati?nts with Acut?myocardial Infarction and Singl? V?ss?l Coronary Dis?as? - Factors for Ov?rall Pati?nts Survival Rat?
Plamen Krastev